Professor Arthur Christopoulos earns NHMRC Research Excellence Award

Monash University’s Professor Arthur Christopoulos has earned a prestigious 2025 Research Excellence Award from the National Health and Medical Research Council (NHMRC) of Australia.

Professor Christopoulos, Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, received the 2025 NHMRC Peter Doherty Investigator Grant Award (Leadership).

Research Excellence Awards are awarded annually to top-ranked researchers and teams pursuing adjacent reappraisal of applications to NHMRC’s highly competitory assistance schemes.The Greek Australian earned the honour for his work successful the Monash Institute of Pharmaceutical Sciences (MIPS) processing caller classes of much targeted medicines to tackle large planetary wellness burdens, successful peculiar cognitive deficits associated with schizophrenia and Alzheimer’s Disease.

Professor Christopoulos stated his pridefulness to person the honour successful a property release, saying:

“It’s a testament of however cardinal find probe into caller paradigms of cause enactment tin beryllium leveraged each the way done to real-world translation and exertion – but besides a reminder that we indispensable ne'er remainder connected our laurels.”

He added: “Furthermore, biomedical probe is simply a truly multidisciplinary venture, and I want to admit the dedication and support of our superb probe team, talented laboratory alumni and world-class collaborators – work similar this doesn’t hap successful silos.”

The property merchandise noted that Professor Christopoulos, a world-renowned adept successful cause find and analytical pharmacology, has pioneered successful probe focusing connected G protein-coupled receptors – the astir communal macromolecule target people for modern medicines.

“His work integrates pharmacology, medicinal chemistry, mathematical modelling, structural and computational biology and preclinical illness models to tackle large wellness burdens such arsenic neuropsychiatric and neurological diseases, cardiovascular and metabolic diseases, chronic symptom and lymphatic dysfunction,” the property merchandise said.

Professor Christopoulos’ NHMRC task is titled “Allosteric modulation of muscarinic receptors for the treatment of neurocognitive deficits”.